Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Functional paralysis of human natural killer cells by alphaherpesviruses.

Campbell TM, McSharry BP, Steain M, Russell TA, Tscharke DC, Kennedy JJ, Slobedman B, Abendroth A.

PLoS Pathog. 2019 Jun 13;15(6):e1007784. doi: 10.1371/journal.ppat.1007784. eCollection 2019 Jun.

2.

Microbial functional amyloids serve diverse purposes for structure, adhesion and defence.

Shanmugam N, Baker MODG, Ball SR, Steain M, Pham CLL, Sunde M.

Biophys Rev. 2019 Jun;11(3):287-302. doi: 10.1007/s12551-019-00526-1. Epub 2019 May 2. Review.

3.

Viral M45 and necroptosis-associated proteins form heteromeric amyloid assemblies.

Pham CL, Shanmugam N, Strange M, O'Carroll A, Brown JW, Sierecki E, Gambin Y, Steain M, Sunde M.

EMBO Rep. 2019 Feb;20(2). pii: e46518. doi: 10.15252/embr.201846518. Epub 2018 Nov 29.

PMID:
30498077
4.

Infection and Functional Modulation of Human Monocytes and Macrophages by Varicella-Zoster Virus.

Kennedy JJ, Steain M, Slobedman B, Abendroth A.

J Virol. 2019 Jan 17;93(3). pii: e01887-18. doi: 10.1128/JVI.01887-18. Print 2019 Feb 1.

PMID:
30404793
5.

RHIM-based protein:protein interactions in microbial defence against programmed cell death by necroptosis.

Baker MODG, Shanmugam N, Pham CLL, Strange M, Steain M, Sunde M.

Semin Cell Dev Biol. 2018 May 22. pii: S1084-9521(17)30394-4. doi: 10.1016/j.semcdb.2018.05.004. [Epub ahead of print] Review.

PMID:
29738881
6.

Varicella zoster virus productively infects human natural killer cells and manipulates phenotype.

Campbell TM, McSharry BP, Steain M, Ashhurst TM, Slobedman B, Abendroth A.

PLoS Pathog. 2018 Apr 30;14(4):e1006999. doi: 10.1371/journal.ppat.1006999. eCollection 2018 Apr.

7.

Varicella-Zoster Virus ORF63 Protects Human Neuronal and Keratinocyte Cell Lines from Apoptosis and Changes Its Localization upon Apoptosis Induction.

Gerada C, Steain M, McSharry BP, Slobedman B, Abendroth A.

J Virol. 2018 May 29;92(12). pii: e00338-18. doi: 10.1128/JVI.00338-18. Print 2018 Jun 15.

8.

Human Cytomegalovirus-Encoded Human Interleukin-10 (IL-10) Homolog Amplifies Its Immunomodulatory Potential by Upregulating Human IL-10 in Monocytes.

Avdic S, McSharry BP, Steain M, Poole E, Sinclair J, Abendroth A, Slobedman B.

J Virol. 2016 Mar 28;90(8):3819-3827. doi: 10.1128/JVI.03066-15. Print 2016 Apr.

9.

Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.

Campbell TM, McSharry BP, Steain M, Slobedman B, Abendroth A.

J Virol. 2015 Aug;89(15):7932-43. doi: 10.1128/JVI.00292-15. Epub 2015 May 20.

10.

Analysis of T cell responses during active varicella-zoster virus reactivation in human ganglia.

Steain M, Sutherland JP, Rodriguez M, Cunningham AL, Slobedman B, Abendroth A.

J Virol. 2014 Mar;88(5):2704-16. doi: 10.1128/JVI.03445-13. Epub 2013 Dec 18.

11.

Varicella-zoster virus glycoprotein I is essential for spread in dorsal root ganglia and facilitates axonal localization of structural virion components in neuronal cultures.

Christensen J, Steain M, Slobedman B, Abendroth A.

J Virol. 2013 Dec;87(24):13719-28. doi: 10.1128/JVI.02293-13. Epub 2013 Oct 9.

12.

Human cytomegalovirus interleukin-10 polarizes monocytes toward a deactivated M2c phenotype to repress host immune responses.

Avdic S, Cao JZ, McSharry BP, Clancy LE, Brown R, Steain M, Gottlieb DJ, Abendroth A, Slobedman B.

J Virol. 2013 Sep;87(18):10273-82. doi: 10.1128/JVI.00912-13. Epub 2013 Jul 17.

13.

T-cell infiltration correlates with CXCL10 expression in ganglia of cynomolgus macaques with reactivated simian varicella virus.

Ouwendijk WJ, Abendroth A, Traina-Dorge V, Getu S, Steain M, Wellish M, Andeweg AC, Osterhaus AD, Gilden D, Verjans GM, Mahalingam R.

J Virol. 2013 Mar;87(5):2979-82. doi: 10.1128/JVI.03181-12. Epub 2012 Dec 26.

14.

Inhibition of integrin α6 expression by cell-free varicella-zoster virus.

Bowles JB, Steain M, Slobedman B, Abendroth A.

J Gen Virol. 2012 Aug;93(Pt 8):1725-30. doi: 10.1099/vir.0.039917-0. Epub 2012 May 16.

PMID:
22592262
15.

Apparent expression of varicella-zoster virus proteins in latency resulting from reactivity of murine and rabbit antibodies with human blood group a determinants in sensory neurons.

Zerboni L, Sobel RA, Lai M, Triglia R, Steain M, Abendroth A, Arvin A.

J Virol. 2012 Jan;86(1):578-83. doi: 10.1128/JVI.05950-11. Epub 2011 Oct 19.

16.
17.

Differentiated neuroblastoma cells provide a highly efficient model for studies of productive varicella-zoster virus infection of neuronal cells.

Christensen J, Steain M, Slobedman B, Abendroth A.

J Virol. 2011 Aug;85(16):8436-42. doi: 10.1128/JVI.00515-11. Epub 2011 Jun 1.

18.

Upregulation of CXCL10 in human dorsal root ganglia during experimental and natural varicella-zoster virus infection.

Steain M, Gowrishankar K, Rodriguez M, Slobedman B, Abendroth A.

J Virol. 2011 Jan;85(1):626-31. doi: 10.1128/JVI.01816-10. Epub 2010 Oct 27.

19.

Characterization of the host immune response in human Ganglia after herpes zoster.

Gowrishankar K, Steain M, Cunningham AL, Rodriguez M, Blumbergs P, Slobedman B, Abendroth A.

J Virol. 2010 Sep;84(17):8861-70. doi: 10.1128/JVI.01020-10. Epub 2010 Jun 23.

20.

Experimental models to study varicella-zoster virus infection of neurons.

Steain M, Slobedman B, Abendroth A.

Curr Top Microbiol Immunol. 2010;342:211-28. doi: 10.1007/82_2010_15. Review.

PMID:
20373093
21.

Detection of influenza A H1N1 and H3N2 mutations conferring resistance to oseltamivir using rolling circle amplification.

Steain MC, Dwyer DE, Hurt AC, Kol C, Saksena NK, Cunningham AL, Wang B.

Antiviral Res. 2009 Dec;84(3):242-8. doi: 10.1016/j.antiviral.2009.09.010. Epub 2009 Oct 1.

PMID:
19800370
22.

Sensitive detection of the K103N non-nucleoside reverse transcriptase inhibitor resistance mutation in treatment-naïve HIV-1 infected individuals by rolling circle amplification.

Wang B, Dwyer DE, Chew CB, Kol C, He ZP, Joshi H, Steain MC, Cunningham AL, Saksena NK.

J Virol Methods. 2009 Oct;161(1):128-35. doi: 10.1016/j.jviromet.2009.06.004. Epub 2009 Jun 11.

PMID:
19523982
23.

The possible contribution of HIV-1-induced syncytia to the generation of intersubtype recombinants in vitro.

Steain MC, Wang B, Saksena NK.

AIDS. 2008 May 31;22(9):1009-17. doi: 10.1097/QAD.0b013e3282f82b6c.

PMID:
18520344
24.

Complex patterns of the HIV-1 epidemic in Kuala Lumpur, Malaysia: evidence for expansion of circulating recombinant form CRF33_01B and detection of multiple other recombinants.

Wang B, Lau KA, Ong LY, Shah M, Steain MC, Foley B, Dwyer DE, Chew CB, Kamarulzaman A, Ng KP, Saksena NK.

Virology. 2007 Oct 25;367(2):288-97. Epub 2007 Jun 29.

25.

Analysis of HIV-1 sequences vertically transmitted to infants in Kisumu, Kenya.

Steain MC, Wang B, Saksena NK.

J Clin Virol. 2006 Aug;36(4):298-302. Epub 2006 Jun 9.

PMID:
16765640
26.

Snapshot of HIV pathogenesis in China.

Saksena NK, Wang B, Steain M, Yang RG, Zhang LQ.

Cell Res. 2005 Nov-Dec;15(11-12):953-61. Review.

27.

HIV-1 co-infection, superinfection and recombination.

Steain MC, Wang B, Dwyer DE, Saksena NK.

Sex Health. 2004;1(4):239-50. Review.

PMID:
16335754
28.

HIV type 1 sequence diversity and dual infections in Kenya.

Steain MC, Wang B, Yang C, Shi YP, Nahlen B, Lal RB, Saksena NK.

AIDS Res Hum Retroviruses. 2005 Oct;21(10):882-5.

PMID:
16225416
29.

Obstacles to successful antiretroviral treatment of HIV-1 infection: problems & perspectives.

Potter SJ, Chew CB, Steain M, Dwyer DE, Saksena NK.

Indian J Med Res. 2004 Jun;119(6):217-37. Review.

PMID:
15243161

Supplemental Content

Loading ...
Support Center